Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 27, 2021

SELL
$68.67 - $84.02 $184,653 - $225,929
-2,689 Closed
0 $0
Q2 2020

Jul 22, 2020

BUY
$74.18 - $108.93 $199,470 - $292,912
2,689 New
2,689 $280,000
Q4 2019

Feb 06, 2020

SELL
$73.04 - $95.72 $202,320 - $265,144
-2,770 Closed
0 $0
Q2 2019

Jul 19, 2019

BUY
$73.52 - $88.7 $203,650 - $245,699
2,770 New
2,770 $235,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.8B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Iq Eq Fund Management (Ireland) LTD Portfolio

Follow Iq Eq Fund Management (Ireland) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iq Eq Fund Management (Ireland) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Iq Eq Fund Management (Ireland) LTD with notifications on news.